Recently, after voluntary application by enterprises, local recommendations, qualification review, experts review, department consultation and other related work procedures, the Zhejiang Provincial Bureau of Economics and Information Technology announced the list of 21 leading enterprises and 26 high-growth enterprises in the biomedical industry in 2023.

This high-growth enterprise review was comprehensively scored from multiple dimensions such as quality and efficiency, R&D innovation, industry leadership, and honorary awards. Jiuyuan Gene is successfully rated as a high-growth enterprise in the biomedical industry in Zhejiang Province, reflecting Jiuyuan's superior performance in R&D innovation, honorary awards, quality and efficiency.